JAK1 and neoplasm: The effect of the drug on modulation of STAT3 phosphorylation may also be linked with the inhibition of upstream proteins such as JAK1/2 and c-Src, as we noticed that it can substantially reduce the constitutive activation of these kinases in tumor cells.